Publikationen, an denen er mitarbeitet Jorge Quiroga Vila (16)

2023

  1. Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases

    BioFactors, Vol. 49, Núm. 4, pp. 912-927

2017

  1. Conversion from calcineurin Inhibitor-Based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation

    Annals of Transplantation, Vol. 22, pp. 141-147

2012

  1. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation

    Transplantation Proceedings

  2. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma

    European Journal of Surgical Oncology, Vol. 38, Núm. 7, pp. 594-601

  3. Subsequent nonmelanoma skin cancer after liver transplantation

    Transplantation Proceedings

2011

  1. Applicability of living donor liver transplantation in a program of adult liver transplantation

    Transplantation Proceedings

  2. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages

    Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971

  3. Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

    Liver Transplantation, Vol. 17, Núm. 4, pp. 402-408

2009

  1. Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report

    Clinical Transplantation, Vol. 23, Núm. 4, pp. 532-536

2008

  1. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria

    Liver Transplantation, Vol. 14, Núm. 3, pp. 272-278

2006

  1. Transplante hepático

    Anales del sistema sanitario de Navarra, Vol. 29, Núm. 2, pp. 93-104

2005

  1. De novo neoplasia after liver transplantation: An analysis of risk factors and influence on survival

    Liver Transplantation, Vol. 11, Núm. 1, pp. 89-97

2004

  1. Herpes zoster after liver transplantation: Incidence, risk factors, and complications

    Liver Transplantation, Vol. 10, Núm. 9, pp. 1140-1143

2003

  1. Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus

    Transplantation Proceedings

  2. Liver Transplant Recipients Older Than 60 Years Have Lower Survival and Higher Incidence of Malignancy

    American Journal of Transplantation, Vol. 3, Núm. 11, pp. 1407-1412

2002

  1. Late liver function with graft obtained from donors above 65 years

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 231-232